Daniel Glickman - CME Independent Director

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:3em;padding-top: 40px;;'>CME</div>
CME -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Mr. Daniel Robert. Glickman is Lead Independent Director of the Company. Mr. Glickman served as our Lead Director from August 2014 to August 2017. Mr. Glickman has served as Executive Director of the Aspen Institutes Congressional Program since 2011 and as Vice President of the Aspen Institute since 2012. Mr. Glickman also has served as Senior Fellow for the Bipartisan Policy Center since 2010. From 2004 to 2010, Mr. Glickman served as Chairman and CEO of the Motion Picture Association of America, Inc. Mr. Glickman previously served as Director of the Institute of Politics at Harvard Universitys John F. Kennedy School of Government from 2002 to 2004 and served as Senior Advisor in the law firm of Akin, Gump, Strauss, Hauer Feld, from 2001 to 2004. He also served as U.S. Secretary of Agriculture from 1995 through 2001 and as a member of the U.S. Congress, representing a district in Kansas, from 1977 through 1995. Mr. Glickman serves as cochair of the global agriculture and development initiative of the Chicago Council on Global Affairs, as a board member of the Foundation for Food and Agriculture Research and Chairman of the International Advisory Board of APCO Worldwide . Mr. Glickman also serves on a number of nonprofit advisory boards with a focus on agriculture and food supply and is a strategic advisor to the Russell Group.
Age: 73  Director Since 2014      
312-930-1000  http://www.cmegroup.com

Daniel Glickman Latest Insider Activity

Daniel Glickman over six months ago via Macroaxis 
CME exotic insider transaction detected
Daniel Glickman over six months ago via Macroaxis 
CME exotic insider transaction detected

Management Efficiency

The company has Return on Asset of 2.12 % which means that on every $100 spent on asset it made $2.12 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 8.12 % implying that it generated $8.12 on every 100 dollars invested.
The company has 3.74 B in debt with debt to equity (D/E) ratio of 14.3 . This implies that the company may be unable to create cash to meet all of its financial commitments. CME Group has Current Ratio of 1.01 demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


Gail LandisMorningstar
Jacques PeroldMSCI
Fred HatfieldIntercontinental Exchange
Benjamin DuPontMSCI
Glenn HutchinsNasdaq
Caroline TsayMorningstar
Nozipho JanuaryBardillAngloGold Ashanti Limited
Robert HaleMSCI
Robert AsheMSCI
Maria RamosAngloGold Ashanti Limited
John MarkeseNasdaq
Paul SturmMorningstar
Sharon BowenIntercontinental Exchange
Marcus SmithMSCI
David HodgsonAngloGold Ashanti Limited
Cheryl FrancisMorningstar
Catherine KinneyMSCI
Linda RieflerMSCI
Vincent TeseIntercontinental Exchange
Duriya FarooquiIntercontinental Exchange
Thomas NoonanIntercontinental Exchange

Company Summary

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in USA and is traded on BATS Exchange.CME Group (CME) is traded on BATS Exchange in USA. It is located in 20 South Wacker Drive and employs 4,590 people. CME Group was previously known as Cme Group and was traded on BATS Exchange under the symbol MX4A. CME is listed under Trading category by Fama And French industry classification.

CME Group Leadership Team

Ana Dutra, Independent DirectorView
Daniel Glickman, Independent DirectorView
Howard Siegel, Independent DirectorView
Kathleen Cronin, Senior Managing Director, General Counsel, Corporate SecretaryView
Dennis Chookaszian, Independent DirectorView
Steven Wollack, Independent DirectorView
William Miller, Independent DirectorView
Derek Sammann, Senior Managing Director - Financial Products and ServicesView
Cees Vermaas, Managing Director & CEO of CME Europe LimitedView
Gedon Hertshten, Independent DirectorView
Elizabeth Cook, Independent TrusteeView
Daniel Kaye, DirectorView
Douglas Monieson, Independent DirectorView
William Knottenbelt, Senior Managing Director, Europe, Middle East, Africa (EMEA)View
John Pietrowhicz, Senior Managing Director - Business Development and Corporate FinanceView
Jeffrey Bernacchi, Independent DirectorView
James Oliff, Independent DirectorView
Sunil Cutinho, President - CME ClearingView
Julie Holzrichter, COO and Sr. Managing DirectorView
Timothy Bitsberger, Independent DirectorView
Bryan Durkin, Chief Commercial Officer and Sr. Managing DirectorView
Patrick Maloney, Independent DirectorView
Dennis Suskind, Independent DirectorView
Alex Pollock, Lead Independent DirectorView
Leo Melamed, Chairman EmeritusView
Charles Carey, Vice Chairman of the BoardView
Hilda Piell, Chief Human Resource Officer, Senior Managing DirectorView
Kimberly Taylor, President of Global Operations, Technology and RiskView
David Wescott, Independent DirectorView
Edemir Pinto, Independent DirectorView
Deborah Lucas, Independent DirectorView
John Sandner, DirectorView
Jack Tobin, Chief Accounting Officer, Managing DirectorView
Larry Gerdes, Independent DirectorView
Phupinder Gill, CEO, Director, Member of Competitive Markets Advisory Council, Member of Executive Committee and Member of Strategic Steering CommitteeView
Linda Rich, Senior Managing Director - Government Relations and Legislative AffairsView
Terry Savage, Independent DirectorView
Bruce Johnson, Independent DirectorView
Julie Winkler, Senior Managing Director - Research and Product DevelopmentView
Ronald Pankau, Independent DirectorView
Kevin Kometer, CIO, Senior Managing DirectorView
Robert Zagotta, Senior Managing Director - Products and ServicesView
Yra Harris, DirectorView
Terrence Duffy, Executive Chairman and President Member of Competitive Markets Advisory Council, Chairman of Executive Committee and Member of Strategic Steering CommitteeView
Michael Spencer, DirectorView
Martin Gepsman, Independent DirectorView
William Hobert, Independent TrusteeView
Sean Tully, Senior Managing Director - Interest Rates, OTC ProductsView
William Shepard, Independent DirectorView

Stock Performance Indicators

Did you try this?

Run Portfolio Suggestion Now


Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

CME Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for CME and SEMAFO INC. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.